recombinant human vascular endothelial growth factor 165 (TargetMol)
TargetMol is a verified supplier 
TargetMol manufactures this product 
94
Structured Review
TargetMol
recombinant human vascular endothelial growth factor 165
Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmps/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
Average 94 stars, based on 1 article reviews
Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmps/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
Average 94 stars, based on 1 article reviews
recombinant human vascular endothelial growth factor 165 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed. Article Snippet: Primary HSCs (phHSCs) were obtained from ScienCell (5300; Carlsbad, CA, USA) and cultured in stellate cell growth medium SteCM (5301; ScienCell). Recombinant:Article Title: Osteocytes Produces RANKL Via Wnt-TGFβ Signaling Axis for Osteoclastogenesis Article Snippet: .. Article Title: Targeting H3K27me3 methyltransferase EZH2 restrains ANGPT2 signaling in choroidal neovascularization. Article Snippet: Aberrant histone-modifying activity drives pathological angiogenesis, yet the epigenetic regulators that govern choroidal neovascularization (CNV) remain poorly defined.. Here we demonstrate that the histone methyltransferase enhancer of zeste homolog 2 (EZH2) and its catalytic product H3K27me3 are markedly elevated in human and mouse CNV lesions.. Vascular endothelial growth factor (VEGF) rapidly induced EZH2 expression in endothelial cells (ECs). Article Title: Osteocytes Produces RANKL Via Wnt-TGFβ Signaling Axis for Osteoclastogenesis Article Snippet: .. Concentration Assay:Article Title: Osteocytes Produces RANKL Via Wnt-TGFβ Signaling Axis for Osteoclastogenesis Article Snippet: .. Article Title: Osteocytes Produces RANKL Via Wnt-TGFβ Signaling Axis for Osteoclastogenesis Article Snippet: .. Saline:Article Title: Targeting H3K27me3 methyltransferase EZH2 restrains ANGPT2 signaling in choroidal neovascularization. Article Snippet: Aberrant histone-modifying activity drives pathological angiogenesis, yet the epigenetic regulators that govern choroidal neovascularization (CNV) remain poorly defined.. Here we demonstrate that the histone methyltransferase enhancer of zeste homolog 2 (EZH2) and its catalytic product H3K27me3 are markedly elevated in human and mouse CNV lesions.. Vascular endothelial growth factor (VEGF) rapidly induced EZH2 expression in endothelial cells (ECs). Incubator:Article Title: Embryoid body-based differentiation of human-induced pluripotent stem cells into cells with a corneal stromal keratocyte phenotype. Article Snippet: Total RNA was isolated from differentiated cells at various time points following differentiation (days 0–21) using RNAiso Plus reagent (TaKaRa, Japan) and chloroform according to the manufacturer’s protocol. .. The hiPSCs were grown on Matrigel- coated (Corning, Corning, New York, USA) plates and kept in a 37°C incubator with 5% CO 2 using basal medium supplemented with Dulbecco's modified Eagle's medium: nutrient mixture F- 12 (DMEM/F12, Thermo Fisher, USA), 1×N- 2 supplement (Thermo Fisher), 1× B- 27 supplement (Thermo Fisher), 0.1 mM minimum essential medium supplemented with non- essential amino acids (Gibco, USA), 0.1 mM 2- mercaptoethanol (Gibco, USA), and 10 ng/mL Modification:Article Title: Embryoid body-based differentiation of human-induced pluripotent stem cells into cells with a corneal stromal keratocyte phenotype. Article Snippet: Total RNA was isolated from differentiated cells at various time points following differentiation (days 0–21) using RNAiso Plus reagent (TaKaRa, Japan) and chloroform according to the manufacturer’s protocol. .. The hiPSCs were grown on Matrigel- coated (Corning, Corning, New York, USA) plates and kept in a 37°C incubator with 5% CO 2 using basal medium supplemented with Dulbecco's modified Eagle's medium: nutrient mixture F- 12 (DMEM/F12, Thermo Fisher, USA), 1×N- 2 supplement (Thermo Fisher), 1× B- 27 supplement (Thermo Fisher), 0.1 mM minimum essential medium supplemented with non- essential amino acids (Gibco, USA), 0.1 mM 2- mercaptoethanol (Gibco, USA), and 10 ng/mL |
